SCHEMBL4018402

SCHEMBL4018402

CC/C=C(/[C]=O)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4018403 1.00
SCHEMBL3409204 0.82 CES2 (0.43)
SCHEMBL18606067 0.79
SCHEMBL18606066 0.79
SCHEMBL2163215 0.79
SCHEMBL2163218 0.79
SCHEMBL10862636 0.79
SCHEMBL9392150 0.77
SCHEMBL10409556 0.75
SCHEMBL28963609 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1626707-A4 SUSTAINED RELEASE FORMULATION OF N-(2-PROPYLPENTANOYL) GLYCINAMIDE AND RELATED COMPOUNDS YISSUM RES DEV CO (IL) 2009-07-01 EP disclosed
EP-1626707-A2 SUSTAINED RELEASE FORMULATION OF N-(2-PROPYLPENTANOYL) GLYCINAMIDE AND RELATED COMPOUNDS Teva Pharmaceutical Industries Limited (IL) 2006-02-22 EP disclosed
WO-2004071421-A2 SUSTAINED RELEASE FORMULATION OF N-(2-PROPYLPENTANOYL) GLYCINAMIDE AND RELATED COMPOUNDS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-08-26 WO disclosed